The Evidence Base
@theevidencebase.bsky.social
Providing the latest news, opinion and insight into hot topics including real-world data, health economics and outcomes research and patient-centric care.
Accelerating #JCA readiness with an #AI-enabled framework for early #PICO identification | #ISPOREurope becarispublishing.com/digital-cont...
Accelerating JCA readiness with an AI-enabled framework for early PICO identification | Becaris Publishing
becarispublishing.com
November 26, 2025 at 2:18 PM
Accelerating #JCA readiness with an #AI-enabled framework for early #PICO identification | #ISPOREurope becarispublishing.com/digital-cont...
Strengthening #RealWorldEvidence for regulators and payers: insights from the recent roundtable discussion | Becaris Publishing becarispublishing.com/digital-cont...
Strengthening real-world evidence for regulators and payers: insights from the recent roundtable discussion | Becaris Publishing
becarispublishing.com
November 26, 2025 at 1:15 PM
Strengthening #RealWorldEvidence for regulators and payers: insights from the recent roundtable discussion | Becaris Publishing becarispublishing.com/digital-cont...
The latest Evidence Insights feature, “Beyond Borders: The Evolving Role of Evidence Transportability” (in partnership with
@lumanity.bsky.social).
Read here >➡️ becarispublishing.com/spotlights/e...
#RWE #EvidenceTransportability #MarketAccess #RWD #RealWorldData #HealthTechnologyAssessment #HEOR
@lumanity.bsky.social).
Read here >➡️ becarispublishing.com/spotlights/e...
#RWE #EvidenceTransportability #MarketAccess #RWD #RealWorldData #HealthTechnologyAssessment #HEOR
November 26, 2025 at 9:37 AM
The latest Evidence Insights feature, “Beyond Borders: The Evolving Role of Evidence Transportability” (in partnership with
@lumanity.bsky.social).
Read here >➡️ becarispublishing.com/spotlights/e...
#RWE #EvidenceTransportability #MarketAccess #RWD #RealWorldData #HealthTechnologyAssessment #HEOR
@lumanity.bsky.social).
Read here >➡️ becarispublishing.com/spotlights/e...
#RWE #EvidenceTransportability #MarketAccess #RWD #RealWorldData #HealthTechnologyAssessment #HEOR
Reposted by The Evidence Base
📢New article alert
New Research Article: "Adherence, treatment utilization, clinical & economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US"
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER
New Research Article: "Adherence, treatment utilization, clinical & economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US"
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER
Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US
Aim: To describe real-world adherence, treatment utilization, vaso-occlusive crises (VOC)
and economic outcomes in patients with sickle cell disease (SCD) with recurrent VOC
treated with L-glutamine, ...
becarispublishing.com
November 25, 2025 at 4:44 PM
📢New article alert
New Research Article: "Adherence, treatment utilization, clinical & economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US"
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER
New Research Article: "Adherence, treatment utilization, clinical & economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US"
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER
Thriving in uncertainty: real-world data as the foundation for life sciences resilience | @inovalon.bsky.social becarispublishing.com/digital-cont...
Thriving in uncertainty: real-world data as the foundation for life sciences resilience | Becaris Publishing
becarispublishing.com
November 25, 2025 at 3:43 PM
Thriving in uncertainty: real-world data as the foundation for life sciences resilience | @inovalon.bsky.social becarispublishing.com/digital-cont...
New IHI public–private partnership ‘UNIFIED’ launched to advance the use of patient-centered endpoints in healthcare evaluation | Becaris Publishing becarispublishing.com/digital-cont...
New IHI public–private partnership ‘UNIFIED’ launched to advance the use of patient-centered endpoints in healthcare evaluation | Becaris Publishing
becarispublishing.com
November 25, 2025 at 1:30 PM
New IHI public–private partnership ‘UNIFIED’ launched to advance the use of patient-centered endpoints in healthcare evaluation | Becaris Publishing becarispublishing.com/digital-cont...
Preparing effective systematic literature reviews and indirect treatment comparisons for joint clinical assessment (JCA) | @thermofishersci.bsky.social #ISPOREurope becarispublishing.com/digital-cont...
Preparing effective systematic literature reviews and indirect treatment comparisons for joint clinical assessment (JCA) | Becaris Publishing
becarispublishing.com
November 24, 2025 at 12:32 PM
Preparing effective systematic literature reviews and indirect treatment comparisons for joint clinical assessment (JCA) | @thermofishersci.bsky.social #ISPOREurope becarispublishing.com/digital-cont...
Reposted by The Evidence Base
📢New article alert
New research: “Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #KidneyDisease #RWE #MAIC #HEOR #ComparativeEffectiveness
New research: “Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #KidneyDisease #RWE #MAIC #HEOR #ComparativeEffectiveness
Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan
Aim: We compared the effects of nefecon, an oral targeted-release budesonide formulation,
and sparsentan, an oral, dual endothelin-angiotensin receptor antagonist, on estimated
glomerular filtration r...
becarispublishing.com
November 20, 2025 at 4:21 PM
📢New article alert
New research: “Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #KidneyDisease #RWE #MAIC #HEOR #ComparativeEffectiveness
New research: “Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #KidneyDisease #RWE #MAIC #HEOR #ComparativeEffectiveness
Reposted by The Evidence Base
📢New article alert
New Research Article on "Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database".
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER
New Research Article on "Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database".
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER
Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database
Aim: To assess the predictive effect of threshold deviations for multiple liver biomarkers
on negative clinical outcomes, including hepatic decompensation, liver transplantation,
and death in patients...
becarispublishing.com
November 20, 2025 at 12:59 PM
📢New article alert
New Research Article on "Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database".
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER
New Research Article on "Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database".
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER
Catch up on the Evidence Insights, "Turning data into evidence: fit-for-purpose RWD in practice."
This feature explores how #claims, #EHRs, #registries, #genomics, and patient-generated data can be combined to deliver reliable #RealWorldEvidence.
Explore here: becarispublishing.com/spotlights/t...
This feature explores how #claims, #EHRs, #registries, #genomics, and patient-generated data can be combined to deliver reliable #RealWorldEvidence.
Explore here: becarispublishing.com/spotlights/t...
November 19, 2025 at 4:58 PM
Catch up on the Evidence Insights, "Turning data into evidence: fit-for-purpose RWD in practice."
This feature explores how #claims, #EHRs, #registries, #genomics, and patient-generated data can be combined to deliver reliable #RealWorldEvidence.
Explore here: becarispublishing.com/spotlights/t...
This feature explores how #claims, #EHRs, #registries, #genomics, and patient-generated data can be combined to deliver reliable #RealWorldEvidence.
Explore here: becarispublishing.com/spotlights/t...
#RealWorldData show #tirzepatide and #semaglutide offer comparable #cardiovascular protection | Becaris Publishing becarispublishing.com/digital-cont...
Real-world data show tirzepatide and semaglutide offer comparable cardiovascular protection | Becaris Publishing
becarispublishing.com
November 19, 2025 at 4:22 PM
#RealWorldData show #tirzepatide and #semaglutide offer comparable #cardiovascular protection | Becaris Publishing becarispublishing.com/digital-cont...
Setting foundations for future use of RWE in safety and effectiveness: Insights from the ICH M14 guideline with Rob Reynolds, GSK | Becaris Publishing becarispublishing.com/digital-cont...
Setting foundations for future use of RWE in safety and effectiveness: Insights from the ICH M14 guideline with Rob Reynolds, GSK | Becaris Publishing
becarispublishing.com
November 19, 2025 at 3:36 PM
Setting foundations for future use of RWE in safety and effectiveness: Insights from the ICH M14 guideline with Rob Reynolds, GSK | Becaris Publishing becarispublishing.com/digital-cont...
Century Health and Memory Treatment Centers #AI collaboration to support development of #RealWorldEvidence in #Alzheimer’s disease | Becaris Publishing becarispublishing.com/digital-cont...
Century Health and Memory Treatment Centers AI collaboration to support development of real-world evidence in Alzheimer’s disease | Becaris Publishing
becarispublishing.com
November 19, 2025 at 2:36 PM
Century Health and Memory Treatment Centers #AI collaboration to support development of #RealWorldEvidence in #Alzheimer’s disease | Becaris Publishing becarispublishing.com/digital-cont...
Accelerating #JCA readiness with an #AI-enabled framework for early #PICO identification | becarispublishing.com/digital-cont...
Accelerating JCA readiness with an AI-enabled framework for early PICO identification | Becaris Publishing
becarispublishing.com
November 19, 2025 at 10:43 AM
Accelerating #JCA readiness with an #AI-enabled framework for early #PICO identification | becarispublishing.com/digital-cont...
“Beyond Borders: The Evolving Role of Evidence Transportability” – developed in partnership with
@lumanity.bsky.social – explores how #RealWorldEvidence can cross borders to inform #HTA and payer decisions globally.
Explore here >> becarispublishing.com/spotlights/e...
@lumanity.bsky.social – explores how #RealWorldEvidence can cross borders to inform #HTA and payer decisions globally.
Explore here >> becarispublishing.com/spotlights/e...
November 18, 2025 at 4:48 PM
“Beyond Borders: The Evolving Role of Evidence Transportability” – developed in partnership with
@lumanity.bsky.social – explores how #RealWorldEvidence can cross borders to inform #HTA and payer decisions globally.
Explore here >> becarispublishing.com/spotlights/e...
@lumanity.bsky.social – explores how #RealWorldEvidence can cross borders to inform #HTA and payer decisions globally.
Explore here >> becarispublishing.com/spotlights/e...
Thriving in uncertainty: real-world data as the foundation for life sciences resilience | @inovalon.bsky.social becarispublishing.com/digital-cont...
Thriving in uncertainty: real-world data as the foundation for life sciences resilience | Becaris Publishing
becarispublishing.com
November 18, 2025 at 9:54 AM
Thriving in uncertainty: real-world data as the foundation for life sciences resilience | @inovalon.bsky.social becarispublishing.com/digital-cont...
Flatiron Health integrates Natera’s #oncology tests into OncoEMR to streamline molecular testing and monitoring in routine care | Becaris Publishing becarispublishing.com/digital-cont...
Flatiron Health integrates Natera’s oncology tests into OncoEMR to streamline molecular testing and monitoring in routine care | Becaris Publishing
becarispublishing.com
November 17, 2025 at 4:28 PM
Flatiron Health integrates Natera’s #oncology tests into OncoEMR to streamline molecular testing and monitoring in routine care | Becaris Publishing becarispublishing.com/digital-cont...
GetReal Conference 2025: Advancing #DataQuality and feasibility to deliver decision-grade #RWE | Becaris Publishing becarispublishing.com/digital-cont...
GetReal Conference 2025: Advancing data quality and feasibility to deliver decision-grade RWE | Becaris Publishing
becarispublishing.com
November 17, 2025 at 10:50 AM
GetReal Conference 2025: Advancing #DataQuality and feasibility to deliver decision-grade #RWE | Becaris Publishing becarispublishing.com/digital-cont...
GetReal Conference 2025: Embedding #PatientCentricity and #DigitalHealth in #RealWorldEvidence generation | Becaris Publishing becarispublishing.com/digital-cont...
GetReal Conference 2025: Embedding patient centricity and digital health in real-world evidence generation | Becaris Publishing
becarispublishing.com
November 14, 2025 at 3:33 PM
GetReal Conference 2025: Embedding #PatientCentricity and #DigitalHealth in #RealWorldEvidence generation | Becaris Publishing becarispublishing.com/digital-cont...
Reposted by The Evidence Base
📢New article alert
New Research Article on “Cost-effectiveness of PD-L1 testing to guide immunotherapy for patients with advanced non-small-cell lung cancer in China”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #CostEffectiveness #Immunotherapy
New Research Article on “Cost-effectiveness of PD-L1 testing to guide immunotherapy for patients with advanced non-small-cell lung cancer in China”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #CostEffectiveness #Immunotherapy
Cost-effectiveness of PD-L1 testing to guide immunotherapy for patients with advanced non-small-cell lung cancer in China
Aim: This study aims to assess the cost-effectiveness of three major programmed death-ligand
1 (PD-L1) immunohistochemistry (IHC) testing assays in guiding immunotherapy for patients
with advanced non...
becarispublishing.com
November 14, 2025 at 10:59 AM
📢New article alert
New Research Article on “Cost-effectiveness of PD-L1 testing to guide immunotherapy for patients with advanced non-small-cell lung cancer in China”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #CostEffectiveness #Immunotherapy
New Research Article on “Cost-effectiveness of PD-L1 testing to guide immunotherapy for patients with advanced non-small-cell lung cancer in China”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #CostEffectiveness #Immunotherapy
Bridging the gap: Enabling equitable access to rare disease therapies through strategic evidence planning | Becaris Publishing becarispublishing.com/digital-cont...
Bridging the gap: Enabling equitable access to rare disease therapies through strategic evidence planning | Becaris Publishing
becarispublishing.com
November 13, 2025 at 1:47 PM
Bridging the gap: Enabling equitable access to rare disease therapies through strategic evidence planning | Becaris Publishing becarispublishing.com/digital-cont...
ISPOR Europe 2025 daily round-ups: Day 3 | Becaris Publishing becarispublishing.com/digital-cont...
ISPOR Europe 2025 daily round-ups: Day 3 | Becaris Publishing
becarispublishing.com
November 12, 2025 at 5:20 PM
ISPOR Europe 2025 daily round-ups: Day 3 | Becaris Publishing becarispublishing.com/digital-cont...
ISPOR Europe 2025 – inside the third plenary: Putting patients at the center of real-world evidence in European decision-making | Becaris Publishing becarispublishing.com/digital-cont...
ISPOR Europe 2025 – inside the third plenary: Putting patients at the center of real-world evidence in European decision-making | Becaris Publishing
becarispublishing.com
November 12, 2025 at 4:57 PM
ISPOR Europe 2025 – inside the third plenary: Putting patients at the center of real-world evidence in European decision-making | Becaris Publishing becarispublishing.com/digital-cont...
The future of recruitment: blending AI, specialism and the human touch | Becaris Publishing becarispublishing.com/digital-cont...
The future of recruitment: blending AI, specialism and the human touch | Becaris Publishing
becarispublishing.com
November 12, 2025 at 3:22 PM
The future of recruitment: blending AI, specialism and the human touch | Becaris Publishing becarispublishing.com/digital-cont...
ISPOR Europe 2025 daily round-ups: Day 2 | Becaris Publishing becarispublishing.com/digital-cont...
ISPOR Europe 2025 daily round-ups: Day 2 | Becaris Publishing
becarispublishing.com
November 12, 2025 at 9:07 AM
ISPOR Europe 2025 daily round-ups: Day 2 | Becaris Publishing becarispublishing.com/digital-cont...